BioPharm

BioPharm October eBook: Best Practices 2018

Issue link: https://www.e-digitaleditions.com/i/1043363

Contents of this Issue

Navigation

Page 2 of 27

BioPharm I N T E R N AT I O N A L eBook Contents T h e S ci e n ce & B u si n e ss o f B i o p h a r m a ce u t i c a ls Static Cover – stock.adobe.com: tilialucida Animated Cover – stock.adobe.com: sinhyu, tilialucida, djama, Alexandr Mitiuc, ӣӣ (Gilwoo Shin), angellodeco. RAW MATERIALS TESTING Analytical Best Practices for Raw Materials Testing Feliza Mirasol The testing of raw materials is essential as raw material quality determines the outcome of biologic product quality. 4 BIOSIMILAR ANALYSIS An Analytical Approach to Biosimilar Drug Development Feliza Mirasol Providing analytical data on the comparison between a biosimilar and the reference product is a primary consideration in the development of biosimilars. 8 GLYCAN ANALYSIS Glycan Analysis Best Practices Susan Haigney Experts discuss best practices for performing glycan analysis. 12 PROTEIN CHARACTERIZATION Complex Protein Studies Demand Dynamic Techniques Rita Peters By adapting techniques from other sciences— and exploring better tools for biologics drug development—researchers are addressing challenges of protein characterization. 18 ANALYTICAL METHODS Best Practices in Analytical Method Development and Testing Mario DiPaola This article discusses why it is important to apply risk analysis, QbD, and DoE in the development of analytical methods. 22 OUTSOURCING Barriers and Solutions to Effective External Collaboration in Biopharma Paul Denny-Gouldson As biopharma companies rapidly change their focus, they may lack the laboratory space, instrumentation, and the scientific knowledge to support biologics research. 26 Ad Index 28 Biopharma Laboratory Best Practices 2018 EDITORIAL Editorial Director Rita Peters rita.peters@ubm.com Senior Editor Agnes M. Shanley agnes.m.shanley@ubm.com Managing Editor Susan Haigney susan.haigney@ubm.com European Editor Felicity Thomas felicity.thomas@ubm.com Science Editor Feliza Mirasol feliza.mirasol@ubm.com Manufacturing Editor Jennifer Markarian jennifer.markarian@ubm.com Associate Editor Amber Lowry amber.lowry@ubm.com Art Director Dan Ward dward@hcl.com Contributing Editors Jill Wechsler, Jim Miller, Eric Langer, Anurag Rathore, and Cynthia A. Challener, PhD Correspondent Sean Milmo (Europe, smilmo@btconnect.com) ADVERTISING Publisher Mike Tracey mike.tracey@ubm.com National Sales Manager Scott Vail scott.vail@ubm.com European Sales Manager Linda Hewitt linda.hewitt@ubm.com European Senior Sales Executive Stephen Cleland stephen.cleland@ubm.com C.A.S.T. Data and List Information Michael Kushner michael.kushner@ubm.com Licensing and Reuse of Content: Contact our official partner, Wright's Media, about available usages, license fees, and award seal artwork at Advanstar@wrightsmedia.com for more information. Please note that Wright's Media is the only authorized company that we've partnered with for Advanstar UBM materials. PRODUCTION Production Manager Jesse Singer jsinger@hcl.com AUDIENCE DEVELOPMENT Audience Development Christine Shappell christine.shappell@ubm.com Thomas W. Ehardt Executive Vice-President, Senior Managing Director, UBM Life Sciences Group Dave Esola VP/Managing Director, Pharm/Science Group UBM Life Sciences © 2018 UBM All rights reser ved. No par t of this publication may be reproduced or transmitted in any form or by any means, electronic or mechanical including by photocopy, recording, or information storage and retrieval without permission in w r i t i n g f r o m t h e p u b l i s h e r. A u t h o r i z a t i o n t o p h o t o c o p y i t e m s f o r i n t e r n a l / e du c a t i o n a l or p er s o n a l u s e, or t h e in t er n a l /e du c a t i o n a l or p er s o n a l u s e o f specific clients is granted by UBM for libraries and other users registered with the Copyright Clearance Center, 222 Rosewood Dr. Danvers, MA 01923, 978-750-8400 f a x 978 - 6 4 6 - 870 0 or v isi t ht tp: // w w w.copyr ight.com online. F or uses beyond those listed above, please direc t your writ ten request to Permission Dept. fa x 732-647-1104 or email: Jillyn.Frommer@ubm.com UBM Americas provides certain customer contact data (such as customers' names, addresses, phone numbers, and e-mail addresses) to third parties who wish to promote relevant products, services, and other opportunities that may be of interest to you. If you do not want UBM Americas to make your contact information available to third parties for marketing purposes, simply call toll-free 866-529-2922 between the hours of 7:30 a.m. and 5 p.m. CST and a customer service representative will assist you in removing your name from UBM Life Sciences' lists. Outside the U.S., please phone 218-740-6477. BioPharm International does not verify any claims or other information appearing in any of the advertisements contained in the publication, and cannot take responsibility for any losses or other damages incurred by readers in reliance of such content. BioPharm International welcomes unsolicited articles, manuscripts, photographs, illustrations, and other materials but cannot be held responsible for their safekeeping or return. To subscribe, call toll-free 888-527-7008. Outside the U.S. call 218-740-6477. www.biopharminternational.com October 2018 BioPharm International eBook 3

Articles in this issue

Links on this page

Archives of this issue

view archives of BioPharm - BioPharm October eBook: Best Practices 2018